Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Camu Camu + ICI for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Longueuil, Quebec
This trial is testing whether a compound called Camu Camu, which is found in berries, can improve the efficacy of a cancer treatment called immune-checkpoint inhibitors. The trial's primary objective is to assess the safety and tolerability of Camu Camu in patients with advanced NSCLC and melanoma.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.